Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization

Annals of Internal Medicine

Volumn 126, Issue 1, 1997, Pages 32-35

  Birdsall, Mary A ^b   Farquhar, Cynthia M ^c   White, Harvey D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HIRSUTISM; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL;

EID: 0031025124     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-1-199701010-00005     Document Type: Article

References (18)

1. Willett WC, Green A. Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al. Relative and absoulute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303-9.
2. Castelli WP. Epidemiology of coronary heart disease: the framingham study. Am J Med. 1984;76:4-12.
3. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Khoke JD, et al. High density liporotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 1989;79:8-15
4. Colditz GA, Willett WC, stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-10
5. Polson DW, Adams J, Wasworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet. 1988;1:870-2
6. Farquhar CM, Birdsall M, Manning P, Mitchell J, France JT. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women Aust N Z J Obstet Gynaecol. 1994;1:870-2
7. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol (Oxf) 1989;30:459-70
8. Dunaif A, Segal KR, Futterweit W, Dobrjanski A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. ovary syndrome. J Clin Endocrinal Metab. 1985;61:946-51
9. Wild RA, Painter RC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome J Clm Endocrinol Metab. 1985;61:946-51.
10. Reaven GM. Banting lecture 1988. Role of insulin resistance in human dis- ease Diabetes. 1988;37:1595-607.
11. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J. 1986;112:432-7.
12. Dahlgren E, Johansson S, Lindstedt G, Knutssin F, Oden A, Janson PO, et al .Women with polycystic ovary syndrome wedge resected in 1956 to 1965 a long-term follow-up focusing on natural history and Circulating hor- mones Fertil Steril 1992;57:505-13.
13. Ferriman D, Gallwey JD. Clinical assessment of body hair grown in women. J Clin Endocrinol Metab. l961;21:1440-7.
14. Adams J. Polson DW, Franks S. Prevalence of polycystic Ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed). 1986;293: 355-9.
15. Vlietetra RE, Kronmal RA, Frye RL, Seth AK, Tristani FE, Killip T 3d Actors affecting the extent and seventy of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis. 1982;2:208-15
16. Birdsall MA, Farquhar CM. Polycystic ovaries in pre and postmenopausal women. Clin Endocrinol (Oxf). 1996;44:269-76.
17. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Tenyear follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-62.
18. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990;54:255-9.